Compound Overviews

What Is GHK-Cu? A Research Overview

Erik Rodriguez, Founder & Research Lead3 min read

GHK-Cu is a copper-binding tripeptide that has been studied extensively in dermal and tissue-research contexts. This overview is for laboratory reference only.

What is GHK-Cu?

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys) — a short peptide of three amino acids bound to a copper ion. It occurs naturally in human plasma and declines with age, which is part of why it has drawn research interest. The copper ion is integral to the molecule.

PropertyDetail
TypeCopper-binding tripeptide
SequenceGly-His-Lys (GHK) + Cu²⁺
CAS number89030-95-5

What research has examined

GHK-Cu is one of the longer-studied peptides in this catalog — its biology has been investigated since the 1970s, when the growth-modulating activity of human serum was traced to the glycyl-histidyl-lysine tripeptide.1 The literature is concentrated in dermal and connective-tissue research:

  • Collagen and extracellular matrix. In fibroblast-culture studies, GHK-Cu stimulated collagen synthesis at very low (picomolar-to-nanomolar) concentrations,2 and in a rat wound model it was reported to increase connective-tissue accumulation in vivo.3
  • Matrix remodeling. Beyond synthesis, GHK-Cu was found to raise matrix metalloproteinase-2 (MMP-2) expression in cultured fibroblasts through a copper-dependent mechanism — a remodeling signal, not just a build-up signal.4
  • Gene-expression and "reset" hypotheses. More recent reviews summarize genome-level data describing GHK-Cu's association with a broad set of regenerative and protective pathways, framing it as a modulator of many cellular programs rather than a single-target agent.5

The recurring observation that serum GHK levels decline with age is one reason researchers describe it as a compound of interest in angiogenesis- and skin-aging research. These are cell-culture and animal findings, presented for scientific reference only.

The copper is part of the molecule

A defining feature of GHK-Cu is that the copper(II) ion is not an additive — it is integral to the complex. Much of the peptide's studied activity in matrix and antioxidant contexts is described as copper-dependent,4 which is why the research literature specifies the -Cu complex rather than the bare GHK tripeptide.

Handling in research settings

GHK-Cu is supplied lyophilized and reconstituted with bacteriostatic water before laboratory use, then refrigerated (2–8°C). The copper complex gives solutions a characteristic blue tint, so colour is sometimes used as a rough visual cue — but identity and purity are properly confirmed by the per-batch Certificate of Analysis (HPLC plus mass-spec), not by appearance. Our reconstitution guide covers concentration calculations for any vial size.

What the research does not establish

GHK-Cu's evidence base is predominantly preclinical — fibroblast cultures, animal wound models, gene-expression analyses, and topical cosmetic studies. Controlled clinical evidence for systemic uses is limited, and Renova makes no human-use, cosmetic, or therapeutic claims. The citations below are provided so researchers can consult the primary literature directly.

Often studied in blends

GHK-Cu is one component of the GLOW research blend (with BPC-157 and TB-500), referenced in combined dermal/repair research.

Related comparisons: BPC-157 vs GHK-Cu · GHK-Cu vs Glutathione.

Verified quality

Renova GHK-Cu ships with a per-batch third-party COA. Confirm your lot with Verify Your Vial.

Explore GHK-Cu →

References

  1. Schlesinger DH, et al. Growth-modulating serum tripeptide is glycyl-histidyl-lysine. Experientia. 1977;33(3):324–325. PMID: 858356.

  2. Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343–346. PMID: 3169264.

  3. Maquart FX, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺ in rat experimental wounds. J Clin Invest. 1993;92(5):2368–2376. PMID: 8227353.

  4. Siméon A, et al. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257–2265. PMID: 11045606. 2

  5. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520.

Questions

Frequently Asked

What is GHK-Cu?

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine plus copper), first isolated from human plasma by Loren Pickart in 1973. It is studied in dermal and tissue-regeneration research.

What is GHK-Cu studied for?

Research examines GHK-Cu for collagen and extracellular-matrix signaling, wound-healing models, and markers of cellular senescence in fibroblasts. These are laboratory and preclinical contexts.

Why is GHK-Cu in the GLOW and KLOW blends?

GHK-Cu is the regenerative/dermal component of the GLOW blend (with BPC-157 and TB-500); KLOW adds KPV for an anti-inflammatory arm. See our GLOW guide for the full breakdown.

How is GHK-Cu supplied and stored?

As a lyophilized powder reconstituted with bacteriostatic water for laboratory use and refrigerated (2–8°C) afterward. Every Renova lot ships with a per-batch third-party COA.

#GHK-Cu#copper peptide#dermal research

Related Compounds

Shop the Research

Keep Reading

Related Research

For Research Use Only · Not For Human Consumption · Renova Wellness